26.90
price up icon0.37%   0.10
after-market アフターアワーズ: 26.90
loading
前日終値:
$26.80
開ける:
$26.46
24時間の取引高:
269.86K
Relative Volume:
0.48
時価総額:
$1.81B
収益:
$71.30M
当期純損益:
$-354.80M
株価収益率:
-4.8122
EPS:
-5.59
ネットキャッシュフロー:
$-356.00M
1週間 パフォーマンス:
-2.18%
1か月 パフォーマンス:
+7.77%
6か月 パフォーマンス:
-18.04%
1年 パフォーマンス:
+53.54%
1日の値動き範囲:
Value
$25.85
$26.94
1週間の範囲:
Value
$25.76
$29.61
52週間の値動き範囲:
Value
$14.02
$53.08

Arvinas Inc Stock (ARVN) Company Profile

Name
名前
Arvinas Inc
Name
セクター
Healthcare (1182)
Name
電話
203-535-1456
Name
住所
395 WINCHESTER AVE, NEW HAVEN, CT
Name
職員
445
Name
Twitter
@ArvinasInc
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
ARVN's Discussions on Twitter

Arvinas Inc Stock (ARVN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-02-14 ダウングレード Citigroup Buy → Neutral
2024-02-01 開始されました Goldman Buy
2023-12-19 アップグレード Wells Fargo Equal Weight → Overweight
2023-12-06 アップグレード Jefferies Hold → Buy
2023-11-20 アップグレード Guggenheim Neutral → Buy
2023-10-23 アップグレード Wedbush Neutral → Outperform
2023-06-26 再開されました Oppenheimer Outperform
2023-01-12 ダウングレード Guggenheim Buy → Neutral
2023-01-03 ダウングレード Wells Fargo Overweight → Equal Weight
2022-09-09 開始されました Barclays Overweight
2022-06-21 開始されました Jefferies Hold
2022-05-09 ダウングレード Wedbush Outperform → Neutral
2022-04-28 開始されました Credit Suisse Outperform
2022-04-06 開始されました Morgan Stanley Equal-Weight
2022-02-11 再開されました BMO Capital Markets Outperform
2022-02-10 開始されました Wells Fargo Overweight
2022-01-19 開始されました Goldman Buy
2021-12-07 開始されました Cowen Outperform
2021-10-14 開始されました SVB Leerink Outperform
2021-09-30 開始されました Stifel Buy
2021-09-09 開始されました BofA Securities Buy
2021-05-21 開始されました UBS Buy
2021-04-21 開始されました Truist Buy
2021-03-31 開始されました BMO Capital Markets Outperform
2020-12-14 アップグレード Oppenheimer Perform → Outperform
2020-06-01 アップグレード Citigroup Neutral → Buy
2020-05-12 開始されました Oppenheimer Perform
2019-12-19 開始されました H.C. Wainwright Buy
2019-11-25 開始されました Guggenheim Buy
2019-10-24 アップグレード Goldman Neutral → Buy
2019-09-25 開始されました Wedbush Outperform
2019-09-12 開始されました BMO Capital Markets Outperform
2019-08-06 開始されました Cantor Fitzgerald Overweight
2019-06-05 ダウングレード Citigroup Buy → Neutral
2019-04-12 開始されました Evercore ISI Outperform
2018-10-22 開始されました Citigroup Buy
2018-10-22 開始されました Goldman Neutral
2018-10-22 開始されました Piper Jaffray Overweight
すべてを表示

Arvinas Inc (ARVN) 最新ニュース

pulisher
Nov 04, 2024

Arvinas's SWOT analysis: biotech stock poised for pivotal trial results - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas's SWOT analysis: biotech stock poised for pivotal trial results By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

Allspring Global Investments Holdings LLC Has $182,000 Stake in Arvinas, Inc. (NASDAQ:ARVN) - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas (NASDAQ:ARVN) Receives Buy Rating from HC Wainwright - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Wedbush Issues Pessimistic Estimate for Arvinas Earnings - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

FY2024 EPS Estimates for Arvinas Cut by Leerink Partnrs - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Arvinas (NASDAQ:ARVN) Price Target Lowered to $40.00 at Oppenheimer - Defense World

Nov 04, 2024
pulisher
Nov 01, 2024

Arvinas Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Oppenheimer cuts Arvinas shares price target to $40 ahead of TACTIVE-U trial - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas' (ARVN) Buy Rating Reiterated at HC Wainwright - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas, Inc. (NASDAQ:ARVN) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Assenagon Asset Management S.A. Invests $3.44 Million in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ... By GuruFocus - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Arvinas Reports Progress in Q3 2024 Financials and Trials - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Arvinas Inc (ARVN) Q3 2024 Earnings: Revenue Soars to $102.4M, B - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas (NASDAQ:ARVN) Trading 4.3% HigherTime to Buy? - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas earnings beat by $0.16, revenue topped estimates - Investing.com Canada

Oct 30, 2024
pulisher
Oct 30, 2024

Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Oct 30, 2024
pulisher
Oct 29, 2024

Arvinas Inc (ARVN) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Arvinas, Inc. (NASDAQ:ARVN) Short Interest Down 12.7% in October - MarketBeat

Oct 29, 2024
pulisher
Oct 25, 2024

We're Hopeful That Arvinas (NASDAQ:ARVN) Will Use Its Cash Wisely - Yahoo Finance

Oct 25, 2024
pulisher
Oct 23, 2024

Arvinas (ARVN): A Small-Cap Biotech with High Growth Potential - Insider Monkey

Oct 23, 2024
pulisher
Oct 23, 2024

Arvinas (ARVN) to Release Earnings on Wednesday - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

8 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey

Oct 23, 2024
pulisher
Oct 22, 2024

Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day - ForexTV.com

Oct 22, 2024
pulisher
Oct 22, 2024

SG Americas Securities LLC Sells 76,236 Shares of Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

'Arvinas stock may double if breast cancer drug beats competition'Stifel By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024 - The Manila Times

Oct 21, 2024
pulisher
Oct 21, 2024

Arvinas to Report Third Quarter 2024 Financial Results and - GlobeNewswire

Oct 21, 2024
pulisher
Oct 20, 2024

(ARVN) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 17, 2024

Arvinas (NASDAQ:ARVN) pops 11% this week, taking one-year gains to 81% - Simply Wall St

Oct 17, 2024
pulisher
Oct 16, 2024

Arvinas: Major Catalyst Ahead, But Its History Gives Me Pause (NASDAQ:ARVN) - Seeking Alpha

Oct 16, 2024
pulisher
Oct 16, 2024

Arvinas (NASDAQ:ARVN) Trading 5.9% HigherWhat's Next? - MarketBeat

Oct 16, 2024
pulisher
Oct 14, 2024

Arvinas, Inc. (NASDAQ:ARVN) Sees Significant Decrease in Short Interest - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

ESR1-Mutated Metastatic Breast Cancer Market to Rise by 2034 | - openPR

Oct 14, 2024
pulisher
Oct 13, 2024

Arvinas, Inc. (NASDAQ:ARVN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 13, 2024
pulisher
Oct 12, 2024

Millennium Management LLC Decreases Stock Holdings in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 12, 2024
pulisher
Oct 11, 2024

A new trading data show Arvinas Inc (ARVN) is showing positive returns. - SETE News

Oct 11, 2024
pulisher
Oct 11, 2024

Market Recap Check: Arvinas Inc (ARVN)’s Positive Finish at 25.01, Up/Down 0.04 - The Dwinnex

Oct 11, 2024
pulisher
Oct 10, 2024

ARVN underperforms with a -3.03 decrease in share price - US Post News

Oct 10, 2024
pulisher
Oct 10, 2024

The Manufacturers Life Insurance Company Sells 24,376 Shares of Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Trend Tracker for (ARVN) - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 08, 2024

Arvinas (NASDAQ:ARVN) Stock Price Up 5.8%Should You Buy? - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Dimensional Fund Advisors LP Buys 29,635 Shares of Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Market Recap Check: Arvinas Inc (ARVN)’s Negative Finish at 24.48, Up/Down -0.89 - The Dwinnex

Oct 04, 2024
pulisher
Oct 03, 2024

Arvinas Inc (ARVN)’s stock price range in the last year - US Post News

Oct 03, 2024
pulisher
Oct 02, 2024

Arvinas (NASDAQ:ARVN) Shares Down 3.5% - MarketBeat

Oct 02, 2024

Arvinas Inc (ARVN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Arvinas Inc (ARVN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Cassidy Sean A
Chief Financial Officer
Feb 23 '24
Sale
47.05
1,702
80,079
181,916
Peck Ronald
Chief Medical Officer
Feb 23 '24
Sale
47.05
1,699
79,938
67,516
Taylor Ian
Chief Scientific Officer
Feb 23 '24
Sale
47.05
1,701
80,032
147,522
Taylor Ian
Chief Scientific Officer
Jan 04 '24
Option Exercise
16.00
8,252
132,032
109,973
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):